Literature DB >> 31242438

Poliosis Circumscripta: A Mark of Melanoma.

Megan D Schollenberger1, Julie E Stein2, Janis M Taube3, Evan J Lipson4.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31242438      PMCID： PMC9305990          DOI： 10.1016/j.amjmed.2019.05.042

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   5.928


× No keyword cloud information.
  6 in total

1.  Histological regression in primary cutaneous melanoma: recognition, prevalence and significance.

Authors:  K Blessing; K M McLaren
Journal:  Histopathology       Date:  1992-04       Impact factor: 5.087

Review 2.  Regression in cutaneous melanoma: a comprehensive review from diagnosis to prognosis.

Authors:  S Ribero; E Moscarella; G Ferrara; S Piana; G Argenziano; C Longo
Journal:  J Eur Acad Dermatol Venereol       Date:  2016-07-12       Impact factor: 6.166

Review 3.  Poliosis circumscripta: overview and underlying causes.

Authors:  Rima Sleiman; Mazen Kurban; Farah Succaria; Ossama Abbas
Journal:  J Am Acad Dermatol       Date:  2013-07-12       Impact factor: 11.527

4.  Prognostic role of histological regression in primary cutaneous melanoma: a systematic review and meta-analysis.

Authors:  M R Gualano; S Osella-Abate; G Scaioli; E Marra; F Bert; E Faure; E S Baduel; E Balagna; P Quaglino; M T Fierro; R Siliquini; S Ribero
Journal:  Br J Dermatol       Date:  2017-11-15       Impact factor: 9.302

5.  Poliosis circumscripta unmasking a scalp melanoma.

Authors:  L Yeo; E Husain; S Rajpara
Journal:  Clin Exp Dermatol       Date:  2014-12-26       Impact factor: 3.470

6.  Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual.

Authors:  Jeffrey E Gershenwald; Richard A Scolyer; Kenneth R Hess; Vernon K Sondak; Georgina V Long; Merrick I Ross; Alexander J Lazar; Mark B Faries; John M Kirkwood; Grant A McArthur; Lauren E Haydu; Alexander M M Eggermont; Keith T Flaherty; Charles M Balch; John F Thompson
Journal:  CA Cancer J Clin       Date:  2017-10-13       Impact factor: 508.702
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.